A poll lists top health issues in battleground states; no COVID-19 vaccine has been tested on children; researchers find a more contagious COVID-19 strain.
As the 2020 election season heats up, voters in battleground states listed coronavirus disease 2019 (COVID-19) and protecting insurance for individuals with preexisting conditions as the top health issues influencing their vote. The poll, conducted by The Commonwealth Fund, surveyed nearly 7500 individuals in 10 battleground states between mid-August and mid-September. Forty percent of respondents said addressing the public health needs and economic costs of COVID-19 was a priority, whereas 39% listed ensuring coverage for those with preexisting conditions as a top concern. Another 20% of voters said lowering the cost of health care was the most important health issue affecting their vote.
Despite numerous trials being carried out to test a COVID-19 vaccine, none of the trial populations include children, prompting concern in some experts who worry about the timeline for making the vaccine available to kids, Business Insider reports. Leading experimental vaccines are now in the final stages of clinical trials and some results are expected as early as next month. Although Pfizer, Moderna, AstraZeneca, and Johnson & Johnson all plan to test their vaccines on children, none have provided a timeline on when such a shot would be available. Leaders of Operation Warp Speed, the US government’s vaccine initiative, have not laid out or mentioned a plan for vaccinating children over the past few months.
A study conducted by researchers at Houston Methodist Hospital found that a more contagious strain of COVID-19 dominates recent coronavirus samples, Reuters reports. The study, which analyses the structure of the novel coronavirus from 2 waves of infection in Houston, included examination of more than 5000 genomes from viruses recovered in the earliest phase of the pandemic. It also includes samples from an ongoing more recent wave of infections. The study has yet to be reviewed by outside experts. According to research, nearly all strains in the second wave had a mutation, D614G, which is known to increase the number of “spikes” on the crown-shaped virus, allowing the virus to bind to and infect more cells.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More